封面
市场调查报告书
商品编码
1391919

鼻乳液喷雾市场:依产品类型、依应用、依年龄层、依配销通路、按地区

Nasal Lotion Spray Market, By Product Type, By Application (Allergy Relief, Sinusitis Treatment, Cold & Flu Relief, Hay Fever Relief and Others, By Age Group, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2023年全球鼻腔喷雾剂市场规模为107.8亿美元,预计到2030年将达到171.1亿美元,在预测期内(2023-2030)增长6.8%年复合成长率(CAGR)的

报告范围 报告详情
基准年 2022年 2023年市场规模 107.8亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 6.80% 2030年市场规模预测 171.1亿美元
图 1. 2023 年鼻腔乳液喷雾剂的全球市场占有率(按地区划分)
鼻腔乳液喷雾市场-IMG1

由于呼吸道疾病和过敏的盛行率不断上升,过去几年鼻腔乳液喷剂的全球市场显着成长。鼻腔乳液喷雾可快速缓解鼻塞和鼻道内的稀薄粘液,使呼吸更容易。它含有生理食盐水和其他药物,可以溶解黏液,使呼吸更容易。与口服药物相比,鼻洗剂和喷雾剂越来越多地被采用,因为它们直接在鼻腔中局部起作用。此外,输送机制的创新使滴鼻剂的使用更加方便。

市场动态:

鼻塞、过敏和其他鼻部疾病盛行率的上升推动了鼻腔乳液喷剂的全球市场。污染水平上升、气候条件变化和久坐的生活方式导致鼻部问题增加。洗鼻剂和喷雾剂因其快速缓解和局部作用而被广泛用于治疗鼻部症状。然而,在新兴市场,人们缺乏对鼻腔乳液喷雾剂优于传统滴鼻剂的认识,这可能会阻碍市场成长。另一个挑战是替代治疗方案的可用性。然而,随着提高疗效和治疗持续时间的研究和开发工作正在进行中,市场扩张的机会很多。主要企业正在投资推出具有先进配方的新产品,以利用现有机会。

鼻部疾病盛行率的增加、老年人口的增加、对鼻腔乳液喷雾剂的需求增加、人们意识的提高以及新产品的推出预计将在预测期内推动全球鼻腔乳液喷雾剂市场。推动成长。

市场公司正忙于获得新开发产品的核准,预计这将在预测期内推动全球鼻腔乳液喷雾市场的成长。 2021 年,药厂 Cipla Limited 宣布其舒马曲坦鼻喷雾20 mg 的简略新药认证(ANDA) 已获得美国食品药物管理局(FDA) 的最终核准。 Cipla 的 Sumatriptan鼻喷雾USP 20mg 是GlaxoSmithKline PlcImitrex鼻喷雾的 AB 级仿製药。

然而,低认知度和可用性低预计将阻碍预测期内全球鼻腔乳液喷剂市场的成长。

本研究的主要特点

  • 该报告详细分析了全球鼻乳液喷雾市场,并提供了以2022年为基准年的预测期(2023-2030)的市场规模和年复合成长率(CAGR%)。
  • 它还阐明了各个细分市场的潜在商机,并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 我们根据公司亮点、产品系列、主要亮点、绩效和策略等参数,对全球鼻乳液喷雾市场的主要企业进行了分析。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的资讯。
  • 全球鼻乳液喷雾市场报告迎合了该行业的各种相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球鼻乳液喷雾市场的各种策略矩阵来促进他们的决策。

目录

第1章研究目的与前提

  • 研究目标
  • 假设
  • 简称

第2章市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第3章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 主要亮点
  • 监管场景
  • 最近的趋势
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 合併、收购和合作

第4章全球鼻洗剂市场 -冠状病毒(COVID-19) 大流行的影响

  • 新型冠状病毒感染疾病(COVID-19)的流行病学
  • 供需面分析
  • 经济影响

第5章全球鼻腔乳液喷雾市场,依产品类型,2023-2030

  • 生理食盐水
  • 类固醇滴鼻剂
  • 抗组织胺滴鼻剂
  • 减充血鼻喷雾喷雾剂
  • 天然/有机滴鼻剂
  • 其他(羟甲唑啉、去氧肾上腺素等)

第6章全球鼻腔乳液喷雾市场,依应用分类,2018-2030

  • 缓解过敏
  • 鼻窦的治疗
  • 缓解感冒和流感
  • 缓解花粉症
  • 其他(防鼻子干燥/发痒等)

第7章全球鼻腔乳液喷雾市场,依年龄段,2018-2030

  • 成人
  • 孩子们
  • 婴儿

第8章全球鼻腔乳液喷雾市场,依配销通路,2018-2030

  • 医院药房
  • 零售药房
  • 电子商务
  • 其他(大型超市、便利商店等)

第9章全球鼻腔乳液喷雾市场,按地区,2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 中东和非洲
  • GCC
  • 以色列
  • 南非
  • 北非
  • 中部非洲
  • 其他中东地区

第10章竞争形势

  • 公司简介
    • GlaxoSmithKline plc
    • Johnson &Johnson
    • Pfizer Inc.
    • Novartis AG
    • AstraZeneca PLC
    • Sanofi SA
    • Merck &Co., Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Mylan NV
    • Perrigo Company plc
    • Prestige Consumer Healthcare Inc
    • NeilMed Pharmaceuticals, Inc
    • Church &Dwight Co., Inc
    • Navage, Inc.
    • Xlear, Inc.

第11章章节

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5946

Global nasal lotion spray market size is estimated to be valued at US$ 10.78 Bn in 2023 and is projected to reach US$ 17.11 Bn by 2030, exhibiting compound annual growth rate (CAGR) of 6.8% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 10.78 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 6.80% 2030 Value Projection: US$ 17.11 Bn
Figure 1. Global Nasal Lotion Spray Market Share (%), By Region, 2023
Nasal Lotion Spray Market - IMG1

Global nasal lotion spray market has been growing significantly over the past few years due to rising prevalence of respiratory diseases and allergies. Nasal lotion sprays provide quick relief from congestion and allow easy breathing by thinning the mucus in nasal passageways. They contain saline solutions or other medications that help loosen mucus and ease respiration. Nasal lotion sprays are increasingly being adopted over oral medications owing to their localized and direct effect on nasal cavities. Furthermore, innovations in delivery mechanisms have made nasal sprays more convenient to use.

Market Dynamics:

The global nasal lotion spray market is driven by rising incidence of nasal congestion, allergies, and other nasal disorders. Growing pollution levels, changing climate conditions, and sedentary lifestyles have contributed to increased nasal problems. Nasal lotion sprays are widely used for treating nasal symptoms owing to quick relief and localized action. However, low awareness about benefits of nasal lotion sprays over traditional nasal sprays in developing regions may hinder market growth. Moreover, availability of alternative treatment options poses a challenge. Nonetheless, ongoing R&D to enhance efficacy and duration of treatment presents high opportunity for market expansion. Key players are investing in new product launches with advanced formulations to capitalize on existing opportunities.

Increasing prevalence of nasal disorders, growing geriatric (aging) population, increasing demand for nasal lotion sprays, growing awareness among people, and introduction of novel products are major factors expected to drive growth of the global nasal lotion spray market during the forecast period.

Market players are indulged in receiving approval for their new developed product and this is expected to drive the growth of the global nasal lotion spray market, over the forecast period. In 2021, Cipla Limited, a pharmaceutical company, announced that it received final approval for its Abbreviated New Drug Application (ANDA) for Sumatriptan Nasal Spray, 20 mg from the U.S. Food and Drug Administration (U.S. FDA). Cipla's Sumatriptan Nasal Spray USP, 20 mg is an AB-rated generic therapeutic equivalent version of GlaxoSmithKline's Imitrex Nasal Spray.

However, lack of awareness and limited availability is expected to hamper the growth of the global nasal lotion spray market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global nasal lotion spray market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global nasal lotion spray market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Novartis AG, AstraZeneca PLC, Sanofi S.A., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Perrigo Company plc, Prestige Consumer Healthcare Inc., NeilMed Pharmaceuticals, Inc., Church & Dwight Co., Inc., Navage, Inc. and Xlear, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global nasal lotion spray market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nasal lotion spray market

Detailed Segmentation:

  • By Product Type:
    • Saline Solution
    • Steroid Nasal Sprays
    • Antihistamine Nasal Sprays
    • Decongestant Nasal Sprays
    • Natural/Organic Nasal Sprays
    • Others (Oxymetazoline, Phenylephrine and Others)
  • By Application:
    • Allergy Relief
    • Sinusitis Treatment
    • Cold & Flu Relief
    • Hay Fever Relief
    • Others (Nasal dryness & itch relief and Others)
  • By Age Group:
    • Adults
    • Children
    • Infants
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • E-commerce
    • Others (Hypermarkets, Convenience Stores, among others)
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top Companies in the Global Nasal Lotion Spray Market:
    • GlaxoSmithKline plc.
    • Johnson & Johnson
    • Pfizer Inc.
    • Novartis AG
    • AstraZeneca PLC
    • Sanofi S.A.
    • Merck & Co., Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Mylan N.V.
    • Perrigo Company plc.
    • Prestige Consumer Healthcare Inc.
    • NeilMed Pharmaceuticals, Inc.
    • Church & Dwight Co., Inc.
    • Navage, Inc.
    • Xlear, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By Age Group
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Nasal Lotion Spray Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Nasal Lotion Spray Market, By Product Type, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Saline Solution
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Steroid Nasal Sprays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Antihistamine Nasal Sprays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Decongestant Nasal Sprays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Natural/Organic Nasal Sprays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others (Oxymetazoline, Phenylephrine and Others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Nasal Lotion Spray Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Allergy Relief
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Sinusitis Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Cold & Flu Relief
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Hay Fever Relief
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others (Nasal dryness & itch relief and Others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Nasal Lotion Spray Market, By Age Group, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Children
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Infants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global Nasal Lotion Spray Market, By Distribution Channel, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • E-commerce
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others (Hypermarkets, Convenience Stores, among others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

9. Global Nasal Lotion Spray Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Sub-region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Sub-region, 2019 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030,(US$ Bn)
  • GCC
  • Israel
  • South Africa
  • North Africa
  • Central Africa
  • Rest of Middle East

10. Competitive Landscape

  • Company Profile
    • GlaxoSmithKline plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Johnson & Johnson
    • Pfizer Inc.
    • Novartis AG
    • AstraZeneca PLC
    • Sanofi S.A.
    • Merck & Co., Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Mylan N.V.
    • Perrigo Company plc
    • Prestige Consumer Healthcare Inc
    • NeilMed Pharmaceuticals, Inc
    • Church & Dwight Co., Inc
    • Navage, Inc.
    • Xlear, Inc.
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us